ClinicalTrials.gg
Active, not recruitingNCT06968741SOPHIA2Updated Nov 19, 2026

A Study to Assess the Safety and Effectiveness of the UrOActive® Artificial Urinary sPHincter (AUS)

An interventional study of Artificial Urinary Sphincter (AUS) in Stress Urinary Incontinence (SUI), sponsored by UroMems SAS. Active, not recruiting at 19 sites in 2 countries. Open to male participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by UroMems SAS · Not applicable, Interventional, and Treatment

How we know

Updated Nov 19, 2026Now Active, not recruiting2 sites removedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Not applicable
Ages
22 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 190 studies in Urinary Incontinence, Stress with a site in United States — 28 open to participants now, 41 under way, 4 of them phase 3. Urinary Incontinence, Stress · United States.

Planned enrollment
63rd of 164
140 · median 99
Started
2025
with 12 others
No phase
109 of 190
18 open now
Primary completion
2026-12
later than 16 of 40 live
Registered
181st of 190
by date

Among the 190 studies in Urinary Incontinence, Stress with a site in United States, this one is the 63rd largest by planned enrollment of the 164 interventional ones that give a count, is one of 13 that started in 2025, is one of 109 with no phase, reaches primary completion later than 16 of the 40 other live ones, and was the 181st registered.

Urinary Incontinence, Stress

655 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.

Browse Urinary Incontinence, Stress studies →

Open to participants now

28 of the 190 studies in Urinary Incontinence, Stress with a site in United States are open now. Recruiting first, the newest first:

23 more — sign in →

All 28 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 76 Urinary Incontinence, Stress studies recruiting now, 43 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.

This study: 22 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 190 studies in Urinary Incontinence, Stress with a site in United States, or all of them as a file.
02

Study summary

Prospective, multicenter, single-arm study

03

Conditions studied

  • Stress Urinary Incontinence (SUI)

Keywords

  • Stress urinary incontinence
  • Artificial urinary sphincters
04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Eligibility criteria

Key Inclusion Criteria:

  • Male subjects aged ≥ 22 years old
  • Able to read, comprehend and willing to sign an form
  • Primary diagnosis of stress urinary incontinence for at least 6 months, as assessed by the investigator
  • Appropriate surgical candidate with no medical or mental condition that would interfere with study procedures or confound study outcomes as assessed by the investigator

Key Exclusion Criteria:

  • Currently enrolled or plans to enroll in another device or clinical drug trial or has completed an investigational study (for urinary incontinence) in the past 3 months prior to informed consent
  • Poor candidate for surgical procedures and/or anesthesia, as determined by investigator
  • Currently implanted with an Active Implantable Medical Device (AIMD)
  • Symptoms or diagnosis of urge incontinence or mixed incontinence (MI) with a predominant urgency component, as assessed by the investigator
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • Experimental
    UroActive AUS Implant

    Enrolled subjects who meet study eligibility criteria will proceed to receive the UroActive Artificial Urinary Sphincter (AUS) device

    Device: Artificial Urinary Sphincter (AUS)

Interventions

  • DeviceArtificial Urinary Sphincter (AUS)

    AUS implant

06

What researchers measure

Primary outcomes

  1. Responder rate at 26 weeks post-activation

    Proportion of subjects who report greater than or equal to 50% reduction in the 24 hour Pad Weight Test (PWT) at 26 weeks compared with Baseline

    Time frame: 26 weeks

Other outcomes

  1. Proportion of subjects reporting change in overall impression of improvement (PGI-I)

    Proportion of subjects reporting change in their overall impression of improvement with the use of their treatment as compared with Baseline

    Time frame: 26 weeks

07

Study locations

19 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Dec 2026, 19 months after the start.

Of 41 industry-sponsored interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 53. This study's planned 19 months is above that.

Counting every sponsor, half of 268 studies reached it within 19 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2025
First posted
May 13, 2025
StartActual
May 19, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2031
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Oct 23, 2026
Sites
2 sites removed
Show 2 removed
  • Cleveland Clinic Foundation · Cleveland, United States
  • Centre Hospitalier Universitaire de Rouen · Rouen, France
Nov 19, 2026
Show all 2 updates
  1. Nov 19, 2026
    2 sites removed
    Show 2 removed
    • Cleveland Clinic Foundation · Cleveland, United States
    • Centre Hospitalier Universitaire de Rouen · Rouen, France
    + 1 other change: verification date
  2. Oct 23, 2026
    Recruiting→Active, not recruiting
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06968741
Lead sponsor
UroMems SAS
Responsible party
Sponsor
First posted
May 13, 2025
Start date
May 19, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2031 (estimated)
Last update
Nov 19, 2026

Study contacts

Roshini Jain
study director · UroMems SAS

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion